{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:43:03Z","timestamp":1773236583467,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":594,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["DE017315"],"award-info":[{"award-number":["DE017315"]}]},{"name":"NIH","award":["CA098428"],"award-info":[{"award-number":["CA098428"]}]},{"name":"NIH","award":["CA022443"],"award-info":[{"award-number":["CA022443"]}]},{"name":"NIH\/NCI","award":["T32 CA090217"],"award-info":[{"award-number":["T32 CA090217"]}]},{"name":"NIH\/NCI","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.virol.2011.09.018","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:33:52Z","timestamp":1318872832000},"page":"114-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dominant role of HPV16 E7 in anal carcinogenesis"],"prefix":"10.1016","volume":"421","author":[{"given":"Marie K.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry C.","family":"Pitot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Liem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2011.09.018_bb0010","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1128\/MCB.23.24.9094-9103.2003","article-title":"Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo","volume":"23","author":"Balsitis","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.virol.2011.09.018_bb0005","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1158\/0008-5472.CAN-06-0984","article-title":"Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis","volume":"66","author":"Balsitis","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0015","first-page":"8173","article-title":"Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer","volume":"63","author":"Brake","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0020","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2011.09.018_bb0025","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus-associated cancers among persons with AIDS","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.virol.2011.09.018_bb0030","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1073\/pnas.89.10.4549","article-title":"Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product","volume":"89","author":"Chellappan","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.09.018_bb0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"Carcinogenicity of human papillomaviruses","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.virol.2011.09.018_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0091-7435(03)00013-6","article-title":"Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973\u20131999","volume":"36","author":"Cress","year":"2003","journal-title":"Prev. Med."},{"key":"10.1016\/j.virol.2011.09.018_bb0045","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1128\/jvi.66.12.6893-6902.1992","article-title":"Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins","volume":"66","author":"Dyson","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.09.018_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/COH.0b013e32831b9c81","article-title":"Human papillomavirus vaccines and anal carcinoma","volume":"4","author":"Franceschi","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virol.2011.09.018_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-immunol-031210-101308","article-title":"Prevention and treatment of papillomavirus-related cancers through immunization","volume":"29","author":"Frazer","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2011.09.018_bb0060","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1128\/jvi.71.8.5905-5914.1997","article-title":"Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice","volume":"71","author":"Gulliver","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.09.018_bb0065","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/jvi.70.3.1873-1881.1996","article-title":"Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene","volume":"70","author":"Herber","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.09.018_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2010.08.003","article-title":"Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice","volume":"407","author":"Jabbar","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.09.018_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2008.10.006","article-title":"The human papillomavirus E7 oncoprotein","volume":"384","author":"McLaughlin-Drubin","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.09.018_bb0190","doi-asserted-by":"crossref","DOI":"10.4161\/hv.7.7.15579","article-title":"Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults","volume":"7","author":"Moreira","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.virol.2011.09.018_bb0085","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2011.09.018_bb0090","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.virol.2011.09.018_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(88)90570-3","article-title":"The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A","volume":"53","author":"Phelps","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.virol.2011.09.018_bb0100","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283023f78","article-title":"Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy","volume":"22","author":"Piketty","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2011.09.018_bb0195","series-title":"SEER Cancer Statistics Review","year":"1975"},{"key":"10.1016\/j.virol.2011.09.018_bb0115","first-page":"4862","article-title":"Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis","volume":"63","author":"Riley","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0120","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/0008-5472.CAN-06-3344","article-title":"The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities","volume":"67","author":"Shai","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0125","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1158\/0008-5472.CAN-08-3711","article-title":"Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis","volume":"69","author":"Shin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0130","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1158\/0008-5472.CAN-05-1651","article-title":"Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential","volume":"65","author":"Simonson","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0135","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1073\/pnas.95.5.2290","article-title":"Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways","volume":"95","author":"Song","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.09.018_bb0145","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.73.7.5887-5893.1999","article-title":"The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals","volume":"73","author":"Song","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.09.018_bb0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/viro.1999.0106","article-title":"Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis","volume":"267","author":"Song","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.09.018_bb0150","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00974-10","article-title":"The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis","volume":"84","author":"Spangle","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.09.018_bb0155","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1940-6207.CAPR-10-0228","article-title":"Rapamycin inhibits anal carcinogenesis in two preclinical animal models","volume":"3","author":"Stelzer","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.virol.2011.09.018_bb0165","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1940-6207.CAPR-10-0086","article-title":"A mouse model for human anal cancer","volume":"3","author":"Stelzer","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.virol.2011.09.018_bb0170","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1158\/0008-5472.CAN-07-3007","article-title":"Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer","volume":"67","author":"Strati","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2011.09.018_bb0175","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1073\/pnas.0606698103","article-title":"Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model","volume":"103","author":"Strati","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.09.018_bb0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.soc.2003.12.005","article-title":"The etiology and epidemiology of anal cancer","volume":"13","author":"Welton","year":"2004","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.virol.2011.09.018_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211004387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211004387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:13:09Z","timestamp":1758586389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682211004387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0042682211004387"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2011.09.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13408993.14779107","asserted-by":"object"}]},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominant role of HPV16 E7 in anal carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2011.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}